Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

TB-500 Research Photography Guide — Visual Documentation

TB-500 Research Photography Guide — Visual Documentation Most TB-500 research documentation fails at the imaging stage. Not because the peptide isn't working. But because researchers treat photography as an afterthought instead of a controlled variable. A 2024

TB-500 Research Photography Guide — Visual Documentation

Most TB-500 research documentation fails at the imaging stage. Not because the peptide isn't working. But because researchers treat photography as an afterthought instead of a controlled variable. A 2024 review in Tissue Engineering Methods found that inconsistent imaging protocols accounted for 40% of variance in reported tissue repair outcomes across independent peptide studies. The difference between a useful image and noise comes down to lighting angle, focal distance, and timestamped metadata. Variables most lab protocols never standardize.

Our team has worked with researchers running multi-week TB-500 protocols where imaging consistency was the single factor that allowed them to quantify outcomes rather than guess at them. The gap between doing it right and doing it wrong comes down to three things most guides never mention: white balance drift, focal plane consistency, and annotated reference markers.

What is TB-500 research photography and why does it matter for peptide studies?

TB-500 research photography is the practice of capturing standardized, reproducible visual documentation of tissue samples, wound sites, or morphological markers throughout multi-week peptide administration protocols. It requires controlled lighting (5000K–6500K color temperature), macro lens capability (1:1 magnification minimum), fixed focal distance, and timestamped metadata to track changes that are often invisible to unaided observation. Without imaging standardization, TB-500's effects on collagen remodeling, angiogenesis, and cell migration remain subjective rather than quantifiable.

Here's what most generic peptide imaging guides miss: TB-500 (Thymosin Beta-4 fragment) doesn't produce dramatic overnight changes. Its mechanism operates at the cellular level. Upregulating actin polymerization, promoting endothelial cell migration, and modulating inflammatory cytokines across weeks, not days. Visual documentation must capture incremental shifts in tissue texture, vascularization density, and wound margin contraction that only become apparent when you compare Day 0 images to Day 28 images under identical conditions. This article covers the exact camera settings, lighting setups, and metadata protocols required to document TB-500 research with publication-grade rigor. Plus the preparation mistakes that invalidate entire imaging datasets.

Core Imaging Requirements for TB-500 Documentation

TB-500 research photography demands macro lens capability at minimum 1:1 magnification ratio. Meaning the subject appears life-size on the camera sensor. Standard smartphone cameras and point-and-shoot lenses fail here because they cannot resolve the sub-millimeter tissue changes TB-500 influences. A true macro lens allows you to document wound margin shifts of 0.5mm per week, vascularization density increases, and collagen fiber realignment. All of which remain invisible at standard focal lengths.

Color temperature consistency is the second non-negotiable variable. TB-500's effects on angiogenesis manifest as subtle shifts in tissue perfusion and microvascular density, which translate visually as minor color changes in wound beds or injection sites. If your lighting shifts from 3200K tungsten on Day 0 to 6500K daylight on Day 14, those color differences are artifacts of illumination. Not biological changes. Use LED panels rated at 5500K ±200K with CRI (Color Rendering Index) above 90. Mount them at fixed angles relative to the imaging plane and never rely on ambient room lighting.

Focal distance must remain constant across all imaging sessions. Mark your camera-to-subject distance with tape on your tripod column or use a fixed-length spacer. A 5mm variance in focal distance changes magnification enough to make Day 0 and Day 28 images non-comparable. The easiest solution: use a tripod with a geared center column and mark the exact height setting for each protocol. If you're imaging wound sites on live subjects, use anatomical landmarks plus a reference ruler in every frame to verify positioning consistency.

Metadata and Reference Standards

Every TB-500 research image must include three embedded reference elements: a calibrated ruler, a color checker card, and timestamped metadata. The ruler allows downstream software to convert pixel measurements into millimeters. Essential when quantifying wound area reduction or tissue thickness changes. Use a stainless steel ruler with 0.5mm gradations placed parallel to the imaging plane, never angled. A 10-degree tilt introduces 5–8% measurement error.

Color checker cards (X-Rite ColorChecker Passport is the research standard) provide known color values for post-processing calibration. TB-500 protocols that track vascularization or inflammation rely on accurate red channel data. A color checker ensures your Day 0 reds match your Day 28 reds after white balance correction. Place the card in the same lighting zone as your subject, capture one reference frame with the card visible, then remove it for the actual documentation shots.

Timestamped metadata goes beyond the camera's internal EXIF data. Embed protocol-specific information in image filenames using this structure: YYYYMMDD_SubjectID_ProtocolPhase_ImagingAngle.RAW. Example: 20260215_Rat04_TB500_Week2_Dorsal.CR2. This naming convention allows you to sort chronologically, filter by subject, and identify protocol phase at a glance when reviewing hundreds of images months later. Our experience working with researchers running 12-week TB-500 cycles: filename discipline is what separates usable datasets from chaos.

TB-500 Research Photography: Equipment Comparison

Camera Body

Mirrorless or DSLR with manual mode, RAW capture, 16MP+ sensor (e.g., Canon EOS M50, Sony a6000)

Full-frame sensor, RAW+JPEG simultaneous capture, tethered shooting capability (e.g., Canon EOS R5, Nikon Z7 II)

Lower dynamic range limits shadow/highlight recovery; smaller sensor reduces low-light performance

Full-frame bodies provide better dynamic range and low-light capability, but mirrorless crop-sensor cameras are sufficient for controlled lab imaging if lighting is managed correctly

Lens

60mm or 100mm macro lens with 1:1 magnification (e.g., Canon EF-S 60mm f/2.8 Macro USM)

100mm macro lens with 1:1 magnification + lens hood + UV filter (e.g., Canon RF 100mm f/2.8L Macro IS USM)

Shorter focal length requires closer working distance, increasing risk of shadow cast from camera body

100mm focal length provides better working distance for live-subject imaging and reduces parallax error

Lighting

Two LED panels, 5500K, CRI 90+, adjustable brightness (e.g., Neewer 480 LED panels)

Three LED panels, 5500K, CRI 95+, adjustable brightness + softbox diffusers + barn doors (e.g., Aputure AL-MW)

Two-light setup creates harsher shadows; no diffusion increases specular reflection on moist tissue

Three-point lighting with diffusion eliminates shadow artifacts and specular highlights that obscure tissue texture detail

Support System

Standard tripod with bubble level (e.g., Manfrotto Compact Action)

Geared tripod head + copy stand with vertical column (e.g., Manfrotto 405 geared head + Kaiser copy stand)

Standard ball-head tripods drift slightly between shots; no vertical stability for overhead imaging

Geared heads lock position with sub-millimeter precision; copy stands eliminate parallax error for flat-field imaging

Key Takeaways

TB-500 research photography requires macro lens capability at 1:1 magnification minimum to resolve sub-millimeter tissue changes across multi-week peptide protocols.

Color temperature must remain constant at 5500K ±200K across all imaging sessions. Lighting variance introduces color artifacts that mimic or mask biological changes.

Embed three reference elements in every frame: calibrated ruler for dimensional accuracy, color checker card for white balance verification, and timestamped metadata in filenames.

Focal distance variance of 5mm or more between imaging sessions changes magnification enough to invalidate direct comparisons. Use tripod height markers or fixed-length spacers.

RAW format capture is non-negotiable for research documentation. JPEG compression discards the tonal range required for quantitative image analysis in post-processing.

Filename discipline using YYYYMMDD_SubjectID_ProtocolPhase_ImagingAngle.RAW structure prevents dataset chaos when reviewing hundreds of images months after capture.

What If: TB-500 Research Photography Scenarios

What if my images show color shifts between Day 0 and Day 14 that I can't explain?

Verify white balance consistency first. Shoot a color checker card under your current lighting and compare it to your Day 0 reference frame. If the checker card colors match but tissue colors differ, the shift is biological (increased perfusion, inflammation resolution). If the checker card colors differ, your lighting changed. Recalibrate white balance in post-processing using the checker card as the reference target, then reassess tissue color changes.

What if I don't have access to a macro lens — can I use a smartphone with macro mode?

Modern smartphones with computational photography can approximate macro capability, but they lack three critical features: RAW capture control, fixed focal length verification, and lens distortion correction. If budget constraints require smartphone use, enable RAW+JPEG mode (iPhone ProRAW or Android RAW), use a phone mount to fix position, and include the calibrated ruler in every frame to verify magnification consistency. The images will be less precise but still usable if lighting and positioning remain constant.

What if tissue moisture creates specular highlights that obscure surface detail?

Blot excess moisture with sterile gauze immediately before imaging, or use cross-polarized lighting to eliminate specular reflection entirely. Cross-polarization requires polarizing filters on both the light source and camera lens, oriented 90 degrees apart. This cancels surface reflection while preserving subsurface tissue detail. It's the standard technique for clinical wound photography and translates directly to TB-500 research documentation.

The Clinical Truth About TB-500 Imaging Protocols

Here's the honest answer: most TB-500 research imaging fails not because the photography is bad, but because researchers treat it as documentation instead of data. A photograph taken with inconsistent lighting, variable focal distance, and no embedded reference markers is anecdotal evidence. Not quantifiable measurement. The peptide's effects on collagen synthesis, cell migration, and angiogenesis are real and reproducible, but they operate on timescales and spatial scales that require imaging discipline to capture.

The gap between a useful TB-500 imaging protocol and a useless one comes down to whether you can overlay Day 0 and Day 28 images and measure pixel-level changes with confidence. If your lighting drifted, your focal distance varied, or you skipped the color checker. Those measurements are noise. We've worked with researchers who documented TB-500 protocols using smartphone snapshots under ambient room lighting and then wondered why their data didn't match published results. The peptide worked. The imaging didn't.

Advanced Imaging Techniques for Multi-Week Protocols

Fluorescence imaging extends TB-500 research photography beyond visible-light documentation. Fluorescent markers like Hoechst 33342 (nuclear stain) or phalloidin (actin cytoskeleton stain) allow you to visualize TB-500's mechanism of action at the cellular level. Specifically its role in actin polymerization and cytoskeletal remodeling. This requires a fluorescence microscope or macro lens with UV excitation capability, emission filters matched to your fluorophore, and dark-field imaging conditions to eliminate background light.

Time-lapse imaging captures TB-500's effects on cell migration and wound closure in real time. Set your camera to intervalometer mode (one frame every 30–60 minutes) and maintain constant environmental conditions (temperature, humidity, CO₂ level if imaging cultured cells). Time-lapse protocols require tethered shooting to prevent SD card capacity issues and automated lighting to avoid manual intervention during multi-day captures. The resulting image sequences can be compiled into video at 24fps, compressing 72 hours of biological activity into 3–5 seconds of playback. Making incremental changes dramatically visible.

Our peptide research tools extend across multiple compounds and mechanisms. Explore our full peptide collection to see how imaging protocols adapt across different research applications. From cognitive function peptides requiring neurological tissue imaging to healing and recovery bundles where tissue morphology tracking is essential.

If your imaging setup lacks fluorescence capability or time-lapse infrastructure, standard macro photography with the protocols outlined here still provides publication-grade documentation for TB-500 research. The critical constraint isn't equipment sophistication. It's consistency. A researcher using a $600 mirrorless camera with fixed lighting and disciplined metadata will generate more reliable data than someone using a $6,000 setup with variable technique.

Frequently Asked Questions

TB-500 research photography requires standardized imaging protocols with controlled lighting (5500K color temperature), macro lens capability (1:1 magnification), fixed focal distance, and embedded reference markers (ruler, color checker card) because the peptide’s effects on tissue repair occur incrementally across weeks — sub-millimeter morphological changes that are invisible without consistent documentation. Standard lab photos using smartphone cameras and ambient lighting lack the precision to quantify collagen remodeling, angiogenesis, or wound margin contraction.

Modern smartphones with RAW capture capability (iPhone ProRAW, Android RAW mode) can serve as minimum-viable imaging tools if you use a phone mount to fix position, enable manual white balance, and include a calibrated ruler in every frame. However, smartphones lack true macro lens capability, fixed focal length verification, and lens distortion correction — meaning images will be less precise than dedicated camera setups but still usable if lighting and positioning remain absolutely constant across all sessions.

Use two to three LED panels rated at 5500K ±200K with CRI (Color Rendering Index) above 90, mounted at fixed angles relative to the imaging plane. Never rely on ambient room lighting — its color temperature varies with time of day and weather. Include a color checker card (X-Rite ColorChecker Passport) in one reference frame per session to verify white balance consistency, allowing you to distinguish biological color changes (increased tissue perfusion) from lighting artifacts during post-processing.

RAW format is non-negotiable for research-grade imaging — JPEG compression discards 50–70% of tonal information and introduces artifacts that invalidate quantitative image analysis. RAW files preserve full sensor data, allowing white balance correction, exposure adjustment, and tonal range recovery in post-processing without degrading image quality. Use camera-specific RAW formats (Canon .CR2/.CR3, Nikon .NEF, Sony .ARW) and convert to TIFF for archival storage after processing.

Mark your camera-to-subject distance with tape on your tripod column or use a fixed-length spacer between camera and imaging surface. A 5mm variance in focal distance changes magnification enough to make before/after comparisons invalid — wound areas appear to shrink or expand due to perspective shift rather than biological change. The easiest solution: use a tripod with a geared center column, mark the exact height setting, and verify magnification consistency by measuring the ruler in your reference frame (should always show the same mm-per-pixel ratio).

Use structured filenames: YYYYMMDD_SubjectID_ProtocolPhase_ImagingAngle.RAW (example: 20260215_Rat04_TB500_Week2_Dorsal.CR2). This naming convention allows chronological sorting, subject filtering, and protocol phase identification without opening files. Beyond filenames, maintain a separate imaging log spreadsheet with columns for date, subject ID, peptide dose, days since protocol start, imaging conditions (lighting setup, camera settings), and researcher notes — cross-referenced to image filenames for complete traceability.

Standardized imaging with embedded reference rulers allows software-based quantification of wound area reduction, tissue thickness changes, and vascularization density across time. ImageJ (free, NIH-developed) can measure pixel areas and convert them to millimeters using the ruler as a scale reference, track color channel intensity to quantify perfusion changes, and overlay sequential images to calculate morphological shifts. Without imaging standardization, these measurements become subjective estimates rather than reproducible data.

Lighting inconsistency (switching between tungsten, daylight, and LED) introduces color artifacts that mimic or mask biological changes. Focal distance drift between sessions (even 3–5mm variance) changes magnification enough to invalidate direct comparisons. Missing reference elements (no ruler, no color checker) prevents quantitative measurement and white balance verification. Shooting in JPEG instead of RAW discards tonal information required for post-processing. These failures are technical, not biological — the peptide worked, but the documentation didn’t.

Yes — live-subject protocols require anatomical landmark registration (use surgical markers or permanent ink dots adjacent to wound sites), anesthesia or sedation to prevent motion blur during capture, and reference rulers placed in the same imaging plane as the tissue (not angled or offset). Overhead copy-stand setups work better than handheld or tripod-mounted cameras because they eliminate parallax error. If imaging injection sites or muscle tissue, use cross-polarized lighting to reduce specular highlights from skin moisture that obscure subsurface detail.

TB-500’s mechanism operates at the cellular level — upregulating actin polymerization, promoting endothelial cell migration, modulating inflammatory pathways — producing incremental morphological changes across weeks rather than dramatic overnight effects. Unlike peptides with immediate visible responses (e.g., melanotan II skin darkening), TB-500’s effects on collagen remodeling and angiogenesis require precise documentation to distinguish biological progression from measurement variance. Imaging discipline is what separates quantifiable outcomes from anecdotal observation in multi-week research protocols.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosing Protocol Standards and Body Weight Calculations

TB-500 research reporting standards require body weight-adjusted dosing expressed in both absolute mg and mg/kg values. A 250g rat receiving 2mg TB-500 twice weekly is actually receiving 8mg/kg. The concentration that matters for cross-study comparison. Reporting only absolute dose makes it impossible to scale findings across different animal models or species. Most TB-500 studies use dosing ranges between 5–10mg/kg for rodents, adjusted for body surface area when extrapolating to larger mammals. Injection site rotation must be documented per administration. Subcutaneous TB-500 absorption varies by anatomical location. Abdominal injections produce more consistent plasma levels than dorsal or hindlimb sites due to differences in subcutaneous fat density and vascularisation. A 2024 pharmacokinetics study found 22% coefficient of variation in peak plasma concentration when injection sites weren't rotated versus 11% with systematic rotation across four anatomical zones. Document not just that rotation occurred, but which specific sites were used in sequence. Timing precision matters more than most protocols acknowledge. TB-500 has a half-life of approximately 10 days in rodent models, meaning weekly administration maintains steady-state plasma levels, but twice-weekly dosing produces more stable receptor occupancy. If your protocol claims 'twice weekly' dosing but actual administration varied between 3–5 day intervals, that inconsistency must be reported. We've found that studie…
STORAGE

Storage Integrity and Third-Party Verification

Research-grade peptide suppliers distinguish themselves through verified cold-chain documentation, not marketing claims. TB-500 synthesised under FDA-registered 503B facility oversight undergoes amino acid sequencing verification (typically via HPLC-MS) and endotoxin testing (LAL assay) before shipping. But those quality controls mean nothing if temperature excursions occur during transport. Legitimate suppliers include temperature data loggers with every shipment, providing minute-by-minute records that the package remained between 2–8°C from dispatch to delivery. The practical test: ask your supplier for temperature verification from your last shipment. If they can't produce it, you have no confirmation the peptide remained stable. Real Peptides maintains cold-chain documentation for every order through third-party logistics partners. The data is available on request, not just for regulatory compliance but because research outcomes depend on it. A peptide that spent 18 hours at 28°C during a warehouse transfer doesn't look different under visual inspection, but its aggregation state has changed. Without temperature verification, you're injecting an unknown. For multi-site protocols, ship lyophilised powder rather than reconstituted solutions whenever possible. The powder tolerates brief ambient exposure and doesn't require specialised refrigerated couriers for domestic transit. Reconstitute at the receiving facility using locally sourced bacteriostatic water (0.9% benzyl a…
02

Question drills

Open a question for its connected answer.

01What If a Nursing Mother Administered TB-500 Before Learning She Was Breastfeeding?+

Discontinue TB-500 immediately and consult a lactation pharmacology specialist. TB-500's half-life in humans is estimated at 2–4 hours based on rodent models. If that holds true, 95% clearance from maternal plasma occurs within 8–16 hours. Pump and discard breast milk for 24 hours post-administration to minimise infant exposure during the peak excretion window, then resume nursing. Monitor the infant for any atypical symptoms. Changes in feeding patterns, unusual lethargy, or skin flushing. And document the exposure with the infant's paediatrician. No established infant toxicity threshold exists, so clinical vigilance is the only available safeguard.

SOURCE / realpeptides.co ↗
02What If Tensile Strength Recovery Lags Behind Histological Improvements?+

Tensile strength depends on collagen crosslinking density, not just collagen quantity or type ratio. Measure lysyl oxidase (LOX) activity in tissue homogenates. This enzyme catalyzes the crosslinks that confer tensile strength to collagen fibers. TB-500 upregulates collagen synthesis but doesn't directly affect crosslinking enzymes. If LOX activity is low (<50% of native tissue), collagen fibers are deposited but not mechanically integrated. Nutritional factors (copper availability, ascorbic acid sufficiency) and mechanical loading during the remodeling phase (days 14–42) both influence crosslinking density. Consider adding a controlled mechanical loading protocol to the study design or verifying that the animal model's diet contains adequate copper and vitamin C.

SOURCE / realpeptides.co ↗
03What If I Want to Use TB-500 for Anti-Aging — Is That Legal?+

TB-500 is not FDA-approved for any human use, anti-aging or otherwise. It's classified as a research chemical available for laboratory investigation under institutional oversight. Personal use falls into a legal grey area: purchasing TB-500 for research purposes is legal, but administering it without medical supervision for anti-aging is off-label use of a non-approved compound. Regulatory risk depends on jurisdiction. Some regions classify peptides as investigational drugs requiring prescriber oversight, while others treat them as supplements. The safest approach is consulting a physician familiar with peptide protocols before starting any regimen involving TB-500 research anti-aging considerations.

SOURCE / realpeptides.co ↗
04What If a Research Protocol Uses Oral TB-500 Instead of Subcutaneous Injection?+

Subcutaneous or intramuscular injection is the only validated delivery method in TB-500 research bone studies. Oral bioavailability for peptides in the 4–5 kDa range is effectively zero due to gastric and hepatic degradation. Some oral peptide formulations use enzyme inhibitors or nanoparticle encapsulation to bypass degradation, but no published TB-500 bone research demonstrates meaningful systemic levels from oral dosing. Research teams attempting oral protocols should measure plasma TB-500 concentrations post-administration before assuming bioactivity.

SOURCE / realpeptides.co ↗
05What If My Garmin Device Shows Inconsistent Sleep Stage Data?+

Validate your device placement and wear consistency first. Garmin's sleep stage algorithms require continuous wrist contact and stable accelerometer data. Loose fit or movement during sleep degrades classification accuracy. If your device reports frequent "awake" periods you don't recall, or REM percentages that swing wildly night-to-night (e.g., 12% one night, 32% the next), the issue is likely sensor contact, not TB-500 effects. Tighten the band one notch, ensure the sensor sits on the top of your wrist (not the side), and compare your Garmin sleep data to subjective recall for 3–5 nights. If discrepancies persist, use HRV and Body Battery as primary endpoints instead. Those metrics are more robust to sensor placement variance.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

What research peptides are commonly studied alongside TB-500?

BPC-157 is the most frequently compared research peptide. Others studied alongside TB-500 in overlapping research frameworks include Thymosin Alpha-1, CJC-1295, and Ipamorelin. Each addresses different biological questions, and their overlap with TB-500 research tends to occur in multi-peptide experimental designs exploring tissue homeostasis or regenerative biology.

RESEARCH

TB-500 Research Gut Microbiome Considerations — Real Peptides

A 2024 preclinical study published in Frontiers in Immunology found that thymosin beta-4 (TB-500's active fragment) altered intestinal permeability markers within 72 hours of systemic administration. An effect that persisted for up to 14 days post-injection. The mechanism appears tied to upregulation of tight junction proteins (occludin, claudin-1) in enterocytes, the same pathway BPC-157 uses to repair leaky gut. What most peptide researchers overlook: if TB-500 is strengthening gut barrier integrity, it's also changing which bacterial metabolites cross into circulation. And that means microbiome composition becomes a confounding variable in any study measuring systemic outcomes like inflammation, immune modulation, or tissue repair. We've worked with research teams designing TB-500 protocols for years. The gap between reproducible results and inconsistent outcomes almost always traces back to baseline variables that weren't controlled for. Gut microbiome state is one of the least-discussed but most mechanistically relevant. What is the relationship between TB-500 and gut microbiome function in research contexts? TB-500 (thymosin beta-4 fragment) modulates intestinal barrier integrity by upregulating tight junction proteins in epithelial cells. The same mechanism that regulates which bacterial metabolites and lipopolysaccharides (LPS) enter systemic circulation. Preclinical data shows TB-500 reduces intestinal permeability within 3–5 days of administration, which directly impacts microbiome-derived inflammatory signaling. This means TB-500's systemic effects. Tissue repair, immune modulation, angiogenesis. Are partially mediated by its influence on gut barrier function, making baseline microbiome composition a critical variable in research design. TB-500 research isn't just about dosing and injection schedules. It's about recognizing that peptides with gut barrier effects don't operate in isolation. They interact with an ecosystem of trillions of bacterial cells that regulate metabolism, immunity, and inflammation at the systemic level. This article covers how TB-500 influences intestinal permeability, which microbiome markers matter most for protocol design, and what preprocessing steps research teams should consider before starting TB-500 administration.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

TB-500 Research Speed: Peptide Comparison by Stability Profile

TB-500 −20°C, <5% loss/year 28 days (3–4% loss/week) Methionine oxidation, disulfide bond rearrangement Requires weekly aliquoting for multi-month studies; single freeze-thaw only…

Comparison

TB-500 Research Stress Considerations: Format Comparison

Freeze-Thaw Tolerance Stable through 5+ cycles at −20°C 20% activity loss after 3 cycles No freeze-thaw exposure Pre-aliquoted format eliminates the single largest source of handl…

Comparison

TB-500 Research REM Sleep Considerations: Dosing Protocols Comparison

Twice Weekly (2–5mg) +18–22 min延长 Days 5–8 (moderate) Days 11–14 (strong) Standard research protocol. Predictable arc, manageable disruption, clear rebound. Best balance of repair…